Suggestions
Sarah Boyce
President and CEO of Avidity Biosciences, Inc.
Sarah Boyce is the President and CEO of Avidity Biosciences, Inc., a pioneering biopharmaceutical company focused on developing RNA therapeutics.12 She joined Avidity in October 2019, bringing over 25 years of global leadership experience in the pharmaceutical and biopharmaceutical industries.23
Career Highlights
Sarah Boyce's career spans several notable companies in the life sciences sector:
- Avidity Biosciences: President and CEO (October 2019 - Present)4
- Akcea Therapeutics: President and Board Member (April 2018 - September 2019)4
- Ionis Pharmaceuticals: Chief Business Officer and Senior Vice President (January 2015 - April 2018)4
- Forest Laboratories: Vice President - International Business Strategy and Operations (2012 - October 2014)4
- Alexion Pharmaceuticals: VP - Nephrology (August 2010 - October 2011)4
- Novartis Vaccines and Diagnostics: Various roles including Vice President, Global Program Head Pediatric and Specialty Business (1999 - 2010)4
Achievements at Avidity Biosciences
Under Sarah Boyce's leadership, Avidity Biosciences has:
- Transitioned from a research-focused entity to a clinical-stage biopharmaceutical company1
- Successfully completed a Series C funding round and an IPO2
- Advanced multiple therapies into clinical development2
- Expanded the company's proprietary RNA technology2
Education and Recognition
Sarah Boyce holds a BSc (Hons) degree in microbiology from the University of Manchester, England.2 Her achievements in the industry have been recognized with several accolades:
- Named a Healthcare Technology Report Top 25 Biotech CEO in 20222
- Recognized as one of the Fiercest Women in Life Sciences2
Board Memberships
In addition to her role at Avidity Biosciences, Sarah Boyce serves on the board of directors for several companies:
Sarah Boyce's leadership at Avidity Biosciences is characterized by her focus on developing transformative treatments for rare diseases and her commitment to leveraging innovative RNA technology to address unmet medical needs.5
Highlights
So apparently it’s national dogs day. Unlike all my posts this one is personal and I’ll share some pics of my dogs. Brownie, the brown stray dog who was on death row before we adopted him. Cookie the OG dog and top dog a German sherpard, husky boxer rescue. Navi the poodle, who once had a fight with a bush you judge who won.
So wonderful to spend time with the incredible interns who joined us this summer. I am so grateful to Life Science Cares for project On-ramp, who helped us find this amazing group. We hosted 9 interns across the company in finance, project management, IT, Chemistry, Biology. Right here are future leaders in biotech.
